Ingredient Studies Again Not Enough For New Nordic Product Claims – NAD
This article was originally published in The Tan Sheet
Executive Summary
Two months after referring advertising for its Hair Volume supplement to FTC, NAD zeroes in on claims for New Nordic USA's Skin Care Collagen Filler supplement. NAD says the firm should discontinue anti-wrinkle and collagen-building claims in the absence of reliable evidence from well-controlled human clinical testing.
You may also be interested in...
Rejecting Nootrobox Cognitive Supplement Claims A No-Brainer For NAD
Cognitive supplements marketer Nootrobox discontinues claims for three of its products because the science supporting the ingredients in the formulas did not also support the products.
NAD Tugs On FTC's Sleeve Again About New Nordic Supplement Claims
New Nordic says it is reformulating its Skin Care Collagen Filler supplement and updating ad claims to more closely reflect its testing, but NAD says the firm is not complying with its recommendations. NAD refers New Nordic claims to FTC for the second time in six months.
GSK/Novartis Support For Benefiber Claims Too Thin To Convince NARB
Referring to rather than providing two studies was GSK/Novartis' downfall in arguing before the National Advertising Review Board to support Benefiber regularity claims. GSK/Novartis questions the panel’s "refusal to accept the full translations of two confirmatory studies referred to in the record."